INVO Bioscience, Inc. (INVO) NASDAQ

0.83

-0.017(-2.00%)

Updated at October 21, 2024 04:00PM

Currency In USD

Valuation

Market Cap2.51M
Enterprise Value10.04B
P/E Ratio-0.03
PEG Ratio0
Price/Sales Ratio0.22
Price/Book Ratio0.2
Enterprise/Revenue1.44
Enterprise/EBITDA-0.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-3.78
Operating Margin-3.68

Management Effectiveness

Return On Assets-0.78
Return On Equity-5.72

Income Statement

Revenue6.53B
Revenue/Share21.3
Gross Profit2.87B
EBITDA-9.51B
Net Income-9.35B
Diluted EPS-3,019.48

Balance Sheet

Total Cash355.89M
Total Cash/Share2.72
Total Debt5.11B
Total Debt/Equity2.65
Current Ratio0.08
Book Value Per Share10.78

Price History

52-Week Change-51.57
52-Week High3.5
52-Week Low0.63
Moving Average 50 Days0.77
Moving Average 200 Days0.9

Statistics

Average Volume1.15M
Shares Outstanding3.91M
% Held by Institutions0.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJuly 28, 2023